John H Abeles - Net Worth and Insider Trading
John H Abeles Net Worth
The estimated net worth of John H Abeles is at least $3 Million dollars as of 2024-05-19. John H Abeles is the Director of Davis Select U.S. Equity ETF and owns about 77,000 shares of Davis Select U.S. Equity ETF (DUSA) stock worth over $3 Million. John H Abeles is also the Director of Medite Cancer Diagnostics Inc and owns about 1,683,202 shares of Medite Cancer Diagnostics Inc (MDIT) stock worth over $168. Details can be seen in John H Abeles's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John H Abeles has not made any transactions after 2018-10-11 and currently still holds the listed stock(s).
Transaction Summary of John H Abeles
John H Abeles Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John H Abeles owns 4 companies in total, including Medite Cancer Diagnostics Inc (MDIT) , Neurotrope Inc (NTRP) , and CombiMatrix Corp (CBMX) among others .
Click here to see the complete history of John H Abeles’s form 4 insider trades.
Insider Ownership Summary of John H Abeles
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MDIT | Medite Cancer Diagnostics Inc | 2018-10-11 | director |
| NTRP | Neurotrope Inc | 2015-11-13 | 10 percent owner |
| CBMX | CombiMatrix Corp | 2012-01-03 | director |
 | | 2005-12-06 | director |
John H Abeles Latest Holdings Summary
John H Abeles currently owns a total of 2 stocks. Among these stocks, John H Abeles owns 77,000 shares of Davis Select U.S. Equity ETF (DUSA) as of December 17, 2009, with a value of $3 Million and a weighting of 99.99%. John H Abeles also owns 1,683,202 shares of Medite Cancer Diagnostics Inc (MDIT) as of October 11, 2018, with a value of $168 and a weighting of 0.01%.
Latest Holdings of John H Abeles
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DUSA | Davis Select U.S. Equity ETF | 2009-12-17 | 77,000 | 40.37 | 3,108,490 |
| MDIT | Medite Cancer Diagnostics Inc | 2018-10-11 | 1,683,202 | 0.00 | 168 |
Holding Weightings of John H Abeles
John H Abeles Form 4 Trading Tracker
According to the SEC Form 4 filings, John H Abeles has made a total of 0 transactions in Davis Select U.S. Equity ETF (DUSA) over the past 5 years. The most-recent trade in Davis Select U.S. Equity ETF is the acquisition of 40,000 shares on December 17, 2009, which cost John H Abeles around $51,200.
According to the SEC Form 4 filings, John H Abeles has made a total of 0 transactions in Medite Cancer Diagnostics Inc (MDIT) over the past 5 years. The most-recent trade in Medite Cancer Diagnostics Inc is the acquisition of 266,667 shares on October 11, 2018, which cost John H Abeles around $21,333.
Insider Trading History of John H Abeles
- 1
John H Abeles Trading Performance
GuruFocus tracks the stock performance after each of John H Abeles's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John H Abeles is -76.11%. GuruFocus also compares John H Abeles's trading performance to market benchmark return within the same time period. The performance of stocks bought by John H Abeles within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John H Abeles's insider trading performs compared to the benchmark.
Performance of John H Abeles
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -54.21 | | | | | |
| Relative Return to S&P 500(%) | -57.52 | | | | | |
John H Abeles Ownership Network
John H Abeles Owned Company Details
What does Medite Cancer Diagnostics Inc do?
Who are the key executives at Medite Cancer Diagnostics Inc?
John H Abeles is the director of Medite Cancer Diagnostics Inc. Other key executives at Medite Cancer Diagnostics Inc include and director & 10 percent owner Lewis William Austin Iv .
Medite Cancer Diagnostics Inc (MDIT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Medite Cancer Diagnostics Inc (MDIT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Medite Cancer Diagnostics Inc (MDIT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Medite Cancer Diagnostics Inc (MDIT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Medite Cancer Diagnostics Inc Insider Transactions
John H Abeles Mailing Address
Above is the net worth, insider trading, and ownership report for John H Abeles. You might contact John H Abeles via mailing address: 2365 Nw 41st Street Boca Raton Fl 33431.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
